This immune response reduced the levels of CD3d, IL-2, IL-2 receptor chain alpha, forkhead box O1 (FOXO1), and nuclear factor of activated T cells 5 (NFAT5); a microenvironment that supports tumor progression (209). The gene discussed is FOXO1; the disease is neoplasm.